CALBIO2012 brings together leaders in life science research with the express purpose of making collaboration happen – to speed up the time, and to lessen the cost it takes to turn discoveries in to treatments and cures.
View 2012 Participants
| 17th Street Legal, PLLC Abbott Abbott Biotech Ventures, Inc. Abbott Laboratories Abingworth Management Inc. Accenture Acurian, Inc. Afraxis Agilent Technologies, Inc. Albemarle Corp Almac Group American Chemical Society Amgen Inc. Amylin Pharmaceuticals, Inc. Amyris, Inc. Anadys Pharmaceuticals, Inc. Apexigen APT Pharmaceuticals Aradigm Corporation ARYx Therapeutics Astex Pharmaceuticals, Inc. Athena Discovery Inc B. Braun Medical Inc. Barney & Barney, LLC Bay City Capital LLC BayBio BayBio Institute BioMarin Pharmaceutical, Inc. BioQuest LLC BioSpace BioStorage Technologies Blazing Star Pharma Advisors Bloomberg Government Boehringer Ingelheim Pharmaceuticals, Inc. Bridgehead International Burrill & Company California Antiviral Foundation California Healthcare Institute Calithera Biosciences Caltherix Inc. Cambridge BioPartners Campbell Alliance Canale Communications Capital Advisors Group, Inc. Cato Research, Ltd. Centella Therapeutics, Inc. Cepheid Cerexa CG Pharmaceuticals Inc. Charter Life Sciences CIPDD/TetraQ, University of Queensland Cleave Biosciences, Inc. Clinical Network Services (CNS) Pty Ltd Contract Pharmaceuticals Limited CRB Consulting Engineers, Inc. Cureline, Inc. Del Mar Pharmaceuticals Dendreon Corporation Dickstein Shapiro DLA Piper LLP (US) Elan Pharmaceuticals, Inc. Elevation Pharmaceuticals, Inc. Elsevier EpiStem Ltd. Ernst & Young LLP Exelixis, Inc. Fabiani & Company Fate Therapeutics Flanders Investment & Trade Frazier Healthcare Ventures Galena BioPharma Gamma Therapeutics, Inc.Genentech Genomics Institute of the Novartis Research Foundation Germany Trade & Invest GmbH GGA Software Services |
Gilead Sciences, Inc. Health Advances, LLC Herrera & Company ImmuMetrix LLC INC Research LLC Innovation Center Denmark International Center for Regulatory Sciences iPierian, Inc. ISTA Pharmaceuticals Kai Pharmaceuticals KDH Systems Khala Consultants King & Spalding LLP Life Science Angels Life Technologies Linear Clinical Research LiquidGrids Lonza, Inc. MabVax Therapeutics, Inc. MacDougall Biomedical Communications, Inc. Merck & Co., Inc. Meritage Pharma MPI Research Myelin Repair Foundation Mytrus NovaBay Pharmaceuticals, Inc. Novartis Diagnostics Novozymes Oncomed Pharmaceuticals Onyx Pharmaceuticals, Inc. Open Monoclonal Technology Optimer Pharmaceuticals Oxford Finance LLC Panorama Capital Pathway Therapeutics, Inc. PCUT BioPartners, Inc. Pfizer Inc. PlenSat, Inc. Point B Capital Prescience International Principia BioPharma, Inc. ProPharma Group Protagonist Therapeutics QuantaLife, Inc QuantumMethod SACTO San Francisco Center for Economic Development (SFCED) Sangart, Inc. Sanofi-Aventis SARcode Bioscience Scottish Development International Sidley Austin, LLP Simon-Kucher & Partners SiteOne Therapeutics Stanford University School of Medicine State of California Employment Training Panel Sunovion Pharmaceuticals, Inc. Synergenics, LLC Takeda Pharmaceuticals North America, Inc. The Communications Strategy Group Inc. Theravance, Inc. Thermo Fisher Scientific Tioga Pharmaceuticals Valley Fever Solutions, Inc. Venrock Associates Versant Ventures VM Pharma LLC VWR International, LLC Wave 80 Biosciences, Inc. Wedbush Securities Wells Fargo Insurance Services WuXi AppTec, Inc. Xencor Inc. Zacharon |
In 2012, participants will include:
- Biotechnology and pharmaceutical companies from California and globally, interested in exchange of best business and operational practices as well as non-profit/for-profit collaborations necessary for the successful commercialization of new therapies
- Philanthropists and investors seeking to invest their funds in a targeted, efficient, and effective manner
- Medical research foundations and institutes that are outcomes-driven and strategic in their allocation of resources
- Thought leaders and innovators with diverse experiences and expertise all committed to expediting the research and development process
- University transfer offices focused on facilitating the transfer of university-developed research results to industry for commercial development purposes
BayBio and BIOCOM built CALBIO2012 on the foundations of their successful annual conferences. The 2011 BayBio annual conference drew close to 1,000 attendees for the conference and over 700 attendees to the Career Fair. In 2011, 163 companies from 14 countries and 22 states represented more than 160 products and innovative technologies.
Previous Attendees Demographics
